• The Global Tuberculosis Drug market is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
• Tuberculosis (TB), known as poor man’s disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air.
• TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys, or the spine. Across the globe, almost two billion people are infected with M. tuberculosis.
• The primary factors driving the global tuberculosis drug market have increased the incidence of TB in Africa and Asia, Emergence of MDR-TB and XDR-TB strains and Increase in an outbreak of TB-HIV co-infection.
• The World Health Organization (WHO) the incidence rates in Asia and Africa are high when compared with America and Europe.
• The incidence rates are high due to lack of infrastructure, inadequate healthcare facilities, socioeconomic, untapped markets, and behavioral issues in these areas.
• Africa has the highest incidence and prevalence rates of TB compared with any other region in the world, with more than three million new TB cases each year.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
